Overview

A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies

Status:
Unknown status

Trial end date:
2020-12-15

Target enrollment:

Participant gender:

Summary

A Randomized, Double-Blind, Placebo-Controlled, Parallel, Multi-Center Study to Assess the Efficacy of BRCX014 Combined with Standard-Of-Care Treatment in Subjects with Glioblastoma Multiforme, Multiple Myeloma, and GI Malignancies

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Leaf Vertical Inc.

Treatments:

Bevacizumab
Bortezomib
Camptothecin
Cannabidiol
Dacarbazine
Gemcitabine
Irinotecan
Leucovorin
Oxaliplatin
Temozolomide